What are the causes of severe hyponatraemia in a cervical cancer patient after pelvic radiotherapy who has severe anaemia, acute kidney injury with hyperkalaemia, low serum osmolality, low urine osmolality, and low‑normal urine sodium?

Severe Hyponatremia in Post-Radiotherapy Cervical Cancer with AKI

In this cervical cancer patient with severe hyponatremia (Na 106), AKI, and hyperkalemia following pelvic radiotherapy, the primary cause is likely SIADH (syndrome of inappropriate antidiuresis) related to cancer and/or treatment, though the low urine osmolality (100 mOsm/kg) is atypical and suggests a more complex picture possibly involving hypovolemia from renal losses or radiation-induced renal injury.

Diagnostic Interpretation

Laboratory Pattern Analysis

The biochemical profile reveals:

• Severe hyponatremia: Sodium 106 mEq/L with low serum osmolality (242 mOsm/kg)
• Low urine osmolality: 100 mOsm/kg (inappropriately dilute for severe hyponatremia)
• Urine sodium: 41 mEq/L (borderline, suggesting some renal sodium loss)
• Concurrent AKI with hyperkalemia: K 6.0 mEq/L

This pattern is atypical for classic SIADH, which would show urine osmolality >100 mOsm/kg and typically >300 mOsm/kg 1. The low urine osmolality suggests either:

1. Partial treatment effect if diuretics were given
2. Hypovolemic hyponatremia with renal salt wasting
3. Mixed pathophysiology

Primary Causes in This Clinical Context

Cancer-Related SIADH is the most common cause of hyponatremia in cancer patients, occurring in 25-45% of lung cancer cases and also seen in cervical cancer 2, 3, 4. In cervical cancer specifically, small cell histology is particularly associated with SIADH 5. The mechanism involves:

• Ectopic vasopressin production by tumor cells
• Nonosmotic AVP release from pain, nausea, stress 1
• Chemotherapy-induced SIADH (cisplatin is a known trigger) 5, 6

Radiation-Induced Renal Injury following pelvic radiotherapy can cause:

• Direct tubular damage affecting concentrating ability
• Salt-wasting nephropathy
• AKI with impaired free water excretion 7

Volume Depletion from:

• Radiation enteritis causing GI losses
• Poor oral intake
• Renal salt wasting 3, 8

Critical Immediate Management Priorities

Life-Threatening Hyperkalemia (K 6.0)

This requires immediate treatment before addressing hyponatremia 9:

1. Stabilize cardiac membrane (within 2-5 minutes):

   • Calcium chloride 10%: 5-10 mL IV over 2-5 minutes, OR
   • Calcium gluconate 10%: 15-30 mL IV over 2-5 minutes

2. Shift potassium intracellularly:

   • Insulin 10 units + 50 mL D50 IV over 15-30 minutes
   • Sodium bicarbonate 50 mEq IV over 5 minutes
   • Nebulized albuterol 10-20 mg over 15 minutes

3. Promote excretion:

   • Furosemide 40-80 mg IV (if not volume depleted)
   • Consider dialysis given severe AKI

Severe Symptomatic Hyponatremia Management

With sodium 106 mEq/L, this patient requires hospitalization in ICU setting 10, 11:

Acute correction protocol (if symptomatic with altered mental status, seizures):

• Correct 6 mEq/L over first 6 hours OR until severe symptoms resolve 11
• Total correction must not exceed 8 mEq/L in 24 hours to prevent osmotic demyelination syndrome 10, 11
• If 6 mEq/L corrected in 6 hours, limit additional correction to 2 mEq/L over next 18 hours

Specific interventions:

1. Fluid restriction: Limit to <1 liter/day initially 10

2. Discontinue contributing factors:

   • Stop diuretics if being used 10
   • Review all medications for SIADH triggers 1

3. Hypertonic saline (3% NaCl) if severely symptomatic 10, 11:

   • Calculate sodium deficit: Desired increase (mEq) × (0.5 × ideal body weight in kg)
   • Administer cautiously with frequent sodium monitoring (every 2 hours)

4. Consider albumin infusion if hypotensive or volume depleted 10

5. Vasopressin receptor antagonists (vaptans) may be considered for refractory SIADH, though reserved for short-term use due to hepatotoxicity risk 10

Diagnostic Workup

Evaluate for non-cirrhotic causes 10:

• Thyroid function (TSH, free T4)
• Adrenal function (morning cortisol, ACTH stimulation test if indicated)
• Infection workup (cultures, imaging)
• Medication review for SIADH-inducing agents 1

Assess volume status carefully:

• Clinical examination for orthostasis, mucous membranes, skin turgor
• Consider central venous pressure monitoring
• Daily weights

Renal function assessment:

• Fractional excretion of sodium
• Urine electrolytes repeated after initial management
• Renal ultrasound to evaluate for obstruction or hydronephrosis (radiation can cause ureteral strictures) 7

Common Pitfalls

1. Overly rapid correction: The greatest risk is osmotic demyelination syndrome with correction >8-10 mEq/L in 24 hours 10, 11

2. Using isotonic saline (0.9% NaCl) inappropriately: In true SIADH with concentrated urine, isotonic saline can paradoxically worsen hyponatremia because the kidneys excrete the sodium while retaining free water 12

3. Missing mixed pathophysiology: The low urine osmolality here suggests this isn't pure SIADH—consider hypovolemia or renal injury 10

4. Ignoring hyperkalemia: This is immediately life-threatening and takes priority over hyponatremia correction 9

5. Overlooking radiation-induced complications: Pelvic radiation can cause enteritis, cystitis, and renal injury that contribute to electrolyte disturbances 7

Ongoing Monitoring

• Sodium levels every 2-4 hours during acute correction phase 11
• Potassium monitoring every 2-4 hours until stable
• Renal function (creatinine, BUN) daily
• Fluid balance (strict intake/output, daily weights)
• Volume status assessment continuously

Prognosis Considerations

Hyponatremia in cancer patients is associated with worse prognosis and increased mortality 2, 3, 4. However, correction of sodium levels is associated with improved outcomes 2. The presence of severe hyponatremia (Na <120) generally indicates advanced disease but appropriate targeted therapy can improve outcomes 3.